Generally, it has been accepted that the sustained and excessive generation of ROS in the liver is closely associated with the pathogenesis of most liver diseases, thus suggesting the therapeutic potential of an Nrf2-mediated inducer of endogenous antioxidant defense system in the development and progression of various liver diseases [6,7]. Here, NFE2L2 is linked to liver disorder.